Physician

Neil Satish Nimkar

According to 2025 Medicare claims, Neil Nimkar (NPI: 1811381890) practices hematology/oncology in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Warren, NJ. This provider's primary affiliated billing organization is PRACTICE ASSOCIATES MEDICAL GROUP (NPI: 1427016385; TIN: 202088165) and primary practice location at 07840-1782. Nimkar is affiliated with the Atlantic ACO (ACO ID: A1026), participating under the MSSP model.

Nimkar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 746 traditional Medicare patients, billed 2,086 HCPCS/CPT codes, and received $179,049 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 531 prescription claims across 132 beneficiaries totaling $672,116 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 76 records totaling $2,159. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $15,325 to $672,116. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$90K$179K2021 Medicare payment: $43,392 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $146,699 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $156,448 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $179,049 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021216371$43,392
20226441,303$146,699
20237211,370$156,448
20247462,086$179,049

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$336K$672K2015 Drug cost: $15,325 (USD; Tot_Drug_Cst)2016 Drug cost: $119,432 (USD; Tot_Drug_Cst)2017 Drug cost: $84,532 (USD; Tot_Drug_Cst)2018 Drug cost: $151,714 (USD; Tot_Drug_Cst)2019 Drug cost: $72,651 (USD; Tot_Drug_Cst)2020 Drug cost: $27,699 (USD; Tot_Drug_Cst)2021 Drug cost: $51,587 (USD; Tot_Drug_Cst)2022 Drug cost: $540,218 (USD; Tot_Drug_Cst)2023 Drug cost: $413,511 (USD; Tot_Drug_Cst)2024 Drug cost: $672,116 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201535171$15,325
20161111,199$119,432
2017103851$84,532
201892865$151,714
201949150$72,651
20202592$27,699
202138175$51,587
202271376$540,218
202383349$413,511
2024132531$672,116

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more9898$178
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more222418$146
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes206232$145
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes188273$99
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more192350$76

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban1023,944$75,259
XareltoRivaroxaban361,080$19,640
SancusoGranisetron15336$12,265
Enoxaparin SodiumEnoxaparin Sodium351,005$10,560
LetrozoleLetrozole262,220$662

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.76$2,159Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Neil Satish Nimkar?

Tedicare shows public-source Medicare data for Neil Satish Nimkar (NPI 1811381890), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Neil Satish Nimkar have ACO affiliation data?

Neil Satish Nimkar is shown with ACO affiliation data for Atlantic ACO (MSSP, ACO ID A1026).

What billing organization is linked to Neil Satish Nimkar?

Neil Satish Nimkar is linked to PRACTICE ASSOCIATES MEDICAL GROUP (billing NPI 1427016385) in the available physician profile data.

Does Neil Satish Nimkar have Open Payments data?

Neil Satish Nimkar has 76 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.